The increasing interest in successful weight management has led to considerable research into cutting-edge treatments. Lately , Retatrutide, a dual -action glucose-dependent insulinotropic polypeptide (GIP) and peptide receptor stimulator, has exhibited promising results in medical trials, suggesting potential for considerable weight reduction . As